Home  »  Company  »  GlaxoSmithKline Pharmaceuticals Ltd.  »  Quotes  »  Audited Results
Enter the first few characters of Company and click 'Go'

Audited Results of GlaxoSmithKline Pharmaceuticals Ltd. Company

(Rs in Cr.) Mar 31, 2023 Mar 31, 2022 Mar 31, 2021 Mar 31, 2020 Mar 31, 2019
Operating Income 3,216.34 3,217.51 2,920.48 3,224.68 3,128.53
Manufacturing Expenses 103.44 121.30 108.04 33.36 27.94
Personnel Expenses 594.99 610.23 616.16 628.55 537.20
Selling Expenses 0 0 0 138.23 0
Administrative Expenses 462.50 429.76 346.03 457.13 595.15
Expenses Capitalised 0 0 0 0 0
Cost Of Sales 2,416.92 2,461.68 2,322.70 2,566.23 2,522.05
Operating Profit 799.43 755.83 597.77 658.45 606.48
Other Recurring Income 101.51 76.22 110.19 77.56 101.48
Adjusted PBDIT 900.94 832.04 707.96 736.01 707.96
Financial Expenses 1.81 1.99 3.53 6.34 0.55
Depreciation 65.77 68.19 78.60 82.68 48.59
Other Write offs 0 0 0 0 0
Adjusted PBT 833.36 761.87 625.83 646.99 658.82
Tax Charges 227.69 396.87 166.54 212.45 238.35
Adjusted PAT 605.67 365 459.29 434.55 420.47
Non Recurring Items 2.08 1,325.53 -101.72 -324.49 4.89
Other Non Cash adjustments 0 0 0 0 0
Reported Net Profit 607.75 1,690.53 357.57 110.05 425.36
Equity Dividend 1,524.66 508.22 677.62 269.17 235.52
Preference Dividend 0 0 0 0 0
Retained Earnings 828.12 1,745.02 562.71 952.41 1,242.11
Get Instant News Updates
Enable
x
Notification Settings X
Time Settings
Done
Clear Notification X
Do you want to clear all the notifications from your inbox?
Settings X